AN11--Research Lab Services - Blood Serum Assay Testing of Buprenorphine and Norbuprenorphine Levels

SOL #: 36C24E26Q0016Sources Sought

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
RPO EAST (36C24E)
PITTSBURGH, PA, 15212, United States

Place of Performance

Boston, Massachusetts

NAICS

Medical Laboratories (621511)

PSC

Health R&D Services; Health Care Services; Basic Research (AN11)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 17, 2026
2
Response Deadline
Feb 24, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA) is conducting a Sources Sought for Research Lab Services to perform Blood Serum Assay Testing of Buprenorphine and Norbuprenorphine Levels. This market research aims to identify qualified businesses for the VA-BRAVE study on opioid use disorder. The primary contractor must be CLIA Certified. Responses are due February 24, 2026, at 3:00 PM EST.

Scope of Work

The requirement involves blood buprenorphine and norbuprenorphine testing for approximately 498 participants, three times over three years, totaling around 1,494 assessments. Key tasks include:

  • Collection of blood toxicology samples.
  • Provision of shipping supplies (e.g., vacutainer tubes, requisition forms, FedEx materials).
  • Development and maintenance of a secure, web-based specimen collection and reporting tool with search, management, printing, and data export capabilities for de-identified participant results and real-time tracking.
  • Blood toxicology screens using GC-MS or LC-MS/MS to determine drug and metabolite concentrations.

Contract & Timeline

  • Opportunity Type: Sources Sought (Market Research)
  • Period of Performance: Base period plus two option years.
  • Place of Performance: Vendor site.
  • Response Due: February 24, 2026, 3:00 PM EST.
  • Published: February 17, 2026.

Submission & Evaluation

Respondents must submit a capability statement demonstrating industry understanding, current knowledge, and subcontracting networks. Required information includes:

  • Company's business status (Large, Small, VOSB, SDVOSB) and any subcontractors' status.
  • SAM.gov Unique Entity ID (UEI).
  • Confirmation of CLIA certification for the primary contractor.
  • Proof of previous experience in the requested services.
  • The primary contractor must perform more than management and administrative functions.

Additional Notes

This is solely for market research; it is not a solicitation. No costs will be paid for responses, and submittals will not be returned. Proprietary information should be clearly marked and segregated. Eligibility for future acquisitions does not depend on a response to this notice. Submissions are by email only to annmarie.stewart@va.gov.

People

Points of Contact

Ann Marie StewartContracting OfficerPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Sources Sought
Posted: Feb 17, 2026
AN11--Research Lab Services - Blood Serum Assay Testing of Buprenorphine and Norbuprenorphine Levels | GovScope